Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells. [electronic resource]
Producer: 20080610Description: 51-60 p. digitalISSN:- 1555-8576
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin D
- Cyclins -- analysis
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- pharmacology
- Drug Synergism
- Etoposide -- pharmacology
- Gossypol -- pharmacology
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Paclitaxel -- pharmacology
- Prednisolone -- therapeutic use
- Tumor Suppressor Protein p53 -- analysis
- Vincristine -- therapeutic use
- bcl-2-Associated X Protein -- analysis
- bcl-X Protein -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.